Blood Safety - Indeterminate HIV-1 Follow-Up
"Long-Term Follow-Up of Blood Donors with Indeterminate Human Immunodeficiency Virus Type 1 Results on Western blot."
Published in AIDS Weekly, April 3rd, 1995
According to the authors' abstract of an article published in Transfusion, "Background: At present, tens of thousands of United States blood donors who are at low risk for human immunodeficiency virus type 1 (HIV-1) infection are indefinitely deferred. These persons are repeatedly reactive for HIV-1 antibody in enzyme immunoassay (EIA) and are indeterminate in Western blot. Study Design and Methods: To determine the significance and persistence of anti-HIV-1 reactivity in plasma from volunteer blood donors with HIV-1-indeterminate Western blots, 66 donors were retested for HIV-1 antibody by the same manufacturers' EIA and Western blot 5 to 7 years after the initial...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1995-04-03)
More Articles from AIDS Weekly
- Conference Coverage
HIV Deceives Immune System - And Vaccine Researchers - Conference Coverage
Salk: Low-Dose Immunization May Be Key to HIV Vaccine - Therapy
Fluconazole Reduces Fungal Infections in AIDS Patients - Animal Models
Newborn Primates Die when Immunized with SIV - At-Risk Populations
Better Education Needed To Prevent Growth of HIV Cases - At-Risk Populations
Computer Assesses HIV Risk - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
